Alper Avci

Alper Avci

Auto-generated profile, based on publicly available information

Alper Avci

Alper Avci Department of Thoracic Surgery, Faculty of Medicine, Cukurova University, Adana, Turkiye

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2021 in Journal of Experimental and Clinical Medicine
Verified
Journal Article
Closed access
YSYasemin Saygideger
Yasemin Saygideger
BDBurcu Saygideger Demir
Burcu Saygideger Demir
Tugba Taskin-TokTugba Taskin-Tok
Tugba Taskin-Tok
AAAlper Avci
Alper Avci
ASAycan Sezan
Aycan Sezan
EOEzgi Ozyilmaz
Ezgi Ozyilmaz
Santolina chameacyparissus (Santo) is an evergreen plant which is traditionally used for its anti-inflammatory effects in various diseases. In this study, we aimed to explore the effects of Santo in non-small cell lung cancer cells. We extracted volatile oil from the plant and evaluated cytotoxicity, apoptosis, and motility effects of the extract on two non-small cell lung cancer (NSCLC) cell lines; one is a patient derived and the other one is a commercially available A549 cells. We also identified its components via GC/MS and investigated possible targets of the major components of the plant using qPCR and docking studies. Cytotoxicity tests showed dose dependent cell killing activity and flow cytometry assays exposed apoptotic effects of Santo. The essential oil also remarkably decreased migration rate of A549 cells, therefore we evaluated the expression levels of epithelial to mesenchymal transition related genes E-cadherin and Vimentin ratio, ZEB1 and SNAIL and another motility related gene Ezrin. Santo did not change the expression of EMT related genes but decreased Ezrin levels. According to the results of the GS/MS analysis, Artemisia ketone and Camphor were identified as major molecules of the extract. Docking analysis also revealed that artemisia ketone, the major component of the Santo extract, potentially showed strong binding to the active site of ezrin protein and both artemisia ketone and camphor had ability to bind DNA. The results of the present study indicate that Santo and its components artemisia ketone and camphor are promising anti-cancer agents, and their potential in targeting DNA and oncogenic proteins in the lung cancer cells seems worth to focus on this plant in cancer related drug discovery science.

24 February 2023 in Turkish Journal of Anaesthesiology and Reanimation
Verified
Journal Article
Open access
FKFeride Karacaer
Feride Karacaer
EBEbru Biricik
Ebru Biricik
MIMurat Ilginel
Murat Ilginel
DTDemet Lafli Tunay
Demet Lafli Tunay
OTOya Baydar Toprak
Oya Baydar Toprak
HUHakki Unlugenc
Hakki Unlugenc
Chronic obstructive pulmonary disease,ketamine,one-lung ventilation,oxygenation,thoracic anaesthesia

23 October 2019 in Turkish Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
AAAlper Avcı
Alper Avcı
ESEzgi Özyılmaz Saraç
Ezgi Özyılmaz Saraç
TETahir Şevval Eren
Tahir Şevval Eren
SOSerdar Onat
Serdar Onat
RÜRefik Ülkü
Refik Ülkü
CÖCemal Özçelik
Cemal Özçelik
Background: This study aims to investigate the risk factors affecting post-traumatic acute respiratory distress syndrome development in thoracic trauma patients. Methods: This two-centered, retrospective study included 3,080 thoracic trauma patients (2,562 males, 518 females; mean age 33.9±19.4 years; range, 2 months to 91 years) treated between January 2005 and January 2019. Demographic characteristics, mechanisms of injury, traumatic injuries, injury severity score and new injury severity score results, treatments, comorbidities, complications, morbidity and mortality rates, and durations of hospital stay were collected. Data were used to predict the risk factors for development of post-traumatic acute respiratory distress syndrome by univariate and multivariate statistical analysis. Results: Acute respiratory distress syndrome was detected in 81 patients. In multivariate logistic regression analysis; age, pulmonary contusion, intracranial hemorrhage, rib fracture (unilateral and four-five pieces), femur and tibia fracture, diabetes mellitus, chronic obstructive pulmonary disease, blood transfusion (?3 units), high white blood cell count at admission, sepsis, and hepatic injury were detected as independent risk factors (p

22 January 2022 in Discover Oncology
Verified
Journal Article
Open access
PDF file
YSYasemin Saygideger
Yasemin Saygideger
AAAlper Avci
Alper Avci
EBEmine Kilic bagir
Emine Kilic bagir
BDBurcu Saygıdeğer Demir
Burcu Saygıdeğer Demir
ASAycan Sezan
Aycan Sezan
ÖEÖzgür Cem Erkin
Özgür Cem Erkin
Objective: Lung cancer displays heterogeneity both in the tumor itself and in its metastatic regions. One interesting behavior of the tumor is known as Skip N2 metastasis, which N2 lymph nodes contain tumor cells while N1 are clean. In this study, mRNA levels of epithelial mesenchymal transition (EMT) related genes in skip N2 and normal N2 involvements of non-small cell lung cancer tissues were investigated to evaluate the possible molecular background that may contribute to the pathogenesis of Skip N2 metastasis. Materials and methods: Eighty-three surgically resected and paraffin embedded lymph node samples of lung cancer patients were analyzed in this study, which 40 of them were Skip N2. N2 tissues were sampled from 50% tumor containing areas and total RNA was extracted. mRNA levels for 18S, E-cadherin, Vimentin, ZEB1 and SLUG were analyzed via qPCR and E-cadherin and vimentin protein levels via immunohistochemistry (IHC). Bioinformatic analysis were adopted using online datasets to evaluate significantly co-expressed genes with SLUG in lung cancer tissue samples. Results: Skip-N2 patients who had adenocarcinoma subtype had better survival rates. Comparative analysis of PCR results indicated that Skip N2 tumor tissues had increased E-Cadherin/Vimentin ratio and ZEB1 mRNA expression, and significantly decreased levels of SLUG. E-cadherin IHC staining were higher in Skip N2 and Vimentin were in Non-Skip N2. TP63 had a strong correlation with SLUG expression in the bioinformatics analyses. Conclusion: The results indicate that, at molecular level, Skip N2 pathogenesis has different molecular background and regulation of SLUG expression may orchestrate the process.

16 September 2019 in Dicle Tıp Dergisi
Verified
Journal Article
Open access
PDF file
MTMediha Turktan
Mediha Turktan
AAAlper Avci
Alper Avci
SGSuat Gezer
Suat Gezer
OSOrhan Kemal Sali̇h
Orhan Kemal Sali̇h
Mediastinoskopi; mediastinal lenf noduevrelemesi için gelişmiş görüntüleme yöntemlerine karşın (transtorasik iğne aspirasyonu, torakoskopik biyopsi, endoskopik ince iğne aspirasyonu gibi) halen altın standart olmaya devam etmektedir. Genellikle güvenli bir işlem olmasına rağmen, pnömotoraks, sol rekürren sinir hasarı, trakeal ya da özefagialrüptür ve büyük damar yaralanması nadir görülen ancak korkulan komplikasyonlardır.Mortaliteye sebep olan en önemli komplikasyonu ise major kanamadır. Bu olgu sunumunda mediastinoskopi sırasında ciddi kanama gelişen ve kardiyopulmoner bypass altında onarım yapılan iki olgunun anestezik yaklaşımı tartışılmıştır.

31 December 2023 in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
Verified
Journal Article
Open access
PDF file
IKİsmail Can Karacaoğlu
İsmail Can Karacaoğlu
CÖCemal Özçeli̇k
Cemal Özçeli̇k
AAAlper Avci̇
Alper Avci̇
SGSuat Gezer
Suat Gezer
Objective: In this study, our aim was to examine the impact of unexpected N2 and potentially resectable N2 groups, which were categorized based on the clinical approach to N2 lymph node involvement, on the survival outcomes of patients who underwent lung resection for non-small cell lung cancer. Specifically, we focused on identifying patients with ipsilateral mediastinal metastatic lymph nodes (N2) and assessing their survival rates. Material and Method: A retrospective cohort study was conducted at a single center, comprising a total of 953 patients who underwent anatomical lung resection and mediastinal lymph node dissection for non-small cell lung cancer (NSCLC) between the years 2011 and 2017. Results: Between January 2011 and December 2017, a retrospective review was conducted on 953 patients who underwent lung resection for non-small cell lung cancer (NSCLC) at our hospital. Patients were categorized into three groups: patients without initial clinical N2 involvement but with postoperative pathological N2 involvement (group 1), patients with initial clinical N2 involvement who underwent immediate surgery (group 2), and patients with initial clinical N2 involvement who demonstrated stable pathological N2 involvement or partial regression after receiving neoadjuvant chemotherapy or chemoradiotherapy and subsequently underwent surgery (group 3). A total of 71 patients (7.45% of the cohort) with postoperative pN2 were included in this study. Among these 71 patients, 41 (57.74%) did not have initial cN2 involvement and were categorized as postoperative pN2 (group 1). Twenty patients (28.16%) with a single cN2 were considered as carefully selected patients and underwent surgery (group 2). Ten patients (14.08%) were selected patients who received neoadjuvant treatment and subsequently had a single N2 involvement, and they underwent anatomical resection (group 3). Statistical analysis revealed no significant differences in survival between the three groups (p=0.882). Conclusion: No consensus currently exists regarding the role of surgery in the management of patients with NSCLC and mediastinal lymph node metastases. Existing evidence suggests that studies encompassing larger patient cohorts are necessary to comprehensively investigate the subgroups of patients with N2 disease.